Locations:

Rheumatology & Immunology

20-RHE-2006261-Deal_Keller_Erdheim-ChesterDisease-CQD-650×450

November 11, 2020/Rheumatology & Immunology/Osteoporosis & Metabolic Bone

Paget Disease in a 36-Year-Old Patient?

Puzzling constellation of findings lead to CT-guided bone biopsy

20-RHE-1956541-DermRheumClinic-HusniFernandez-CQD-650×450

November 6, 2020/Dermatology & Plastic Surgery

Collaborative Rheumatology-Dermatology Clinic Improves Outcomes

Co-management increases opportunities for research and education

November 4, 2020/COVID-19

IL-6 Targeting in COVID-19 Treatment

Safety and efficacy remain in question

20-RHE-1996207-Ungprasert_Systemic-LupusErythematosus-Asthma-CQD-650×450

November 3, 2020/Pulmonary

Assessing the Relationship Between Systemic Lupus Erythematosus and Asthma

Study finds patients with asthma are at higher risk for developing SLE

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

October 21, 2020/COVID-19

Cytokine Storm and the Prospects for Immunotherapy With COVID-19

Anti-IL-6 and anti-IL-1 agents: Center stage for COVID-19 stage 3 disease

20-RHE-1935445-Chatterjee_Parvovirus-associatedArthritis-CQD-650×450

October 20, 2020/Rheumatology & Immunology/Immunologic Diseases

Case Report: Malar Rash, Polyarthritis and Positive ANA

Is it lupus?

20-RHE-1917015-Brown_SucacSyndrome-CQD-650×450

September 8, 2020/Neurosciences

Elucidating the Pathophysiology of Susac Syndrome

The search for new therapeutic targets

17-RHE-1177 Deal_ConsultQD_Hero Image_650x450pxl

September 2, 2020/Rheumatology & Immunology/Osteoporosis & Metabolic Bone

Rapid Bone Loss and Multiple Vertebral Fractures After Denosumab Cessation

If denosumab is stopped, it should be replaced with another osteoporosis treatment

20-PSX-1944052-Cutaneous-adverseEffects-surface-targeted-monoclonal-antibodies-CQD-650×450

August 20, 2020/Cancer

Cutaneous Adverse Effects of Surface-Targeted Monoclonal Antibodies

Side effects and management strategies

20-PSX-1944053-Cutaneous-adverseEffects-TKIs-hero-CQD-650×450

August 17, 2020/Cancer

Cutaneous Adverse Effects of Small-Molecule Tyrosine Kinase Inhibitors

Side effects and management strategies

BackPage 11 of 24Next